Why the study?
Do single-pill combinations improve adherence, persistence, and SBP levels compared to free-equivalent combinations in patients with hypertension and dyslipidemia?
Do single-pill combinations improve adherence, persistence, and SBP levels compared to free-equivalent combinations in patients with hypertension and dyslipidemia?
Single-pill combinations significantly improve medication adherence, persistence, and systolic blood pressure control compared to taking the same medications separately.
Supports SPC preference over separate agents to improve adherence and SBP control in hypertension; confirms meta-analytic benefits for fixed-dose regimens.
SPC use resulted in significantly improved adherence, persistence, and SBP levels compared with FEC in patients with hypertension. The findings support SPC use in reducing the burden of hypertension and dyslipidemia.
No takes yet. Share an insight, caveat, or question.
Kengne et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: